JPS59175435A - 虫歯治療剤 - Google Patents
虫歯治療剤Info
- Publication number
- JPS59175435A JPS59175435A JP58044537A JP4453783A JPS59175435A JP S59175435 A JPS59175435 A JP S59175435A JP 58044537 A JP58044537 A JP 58044537A JP 4453783 A JP4453783 A JP 4453783A JP S59175435 A JPS59175435 A JP S59175435A
- Authority
- JP
- Japan
- Prior art keywords
- caries
- solution
- teeth
- group
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000002925 dental caries Diseases 0.000 title claims description 24
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 230000000675 anti-caries Effects 0.000 claims description 33
- 239000003814 drug Substances 0.000 claims description 20
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 19
- 239000011707 mineral Substances 0.000 claims description 19
- 235000010755 mineral Nutrition 0.000 claims description 19
- 239000004615 ingredient Substances 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 14
- 239000004480 active ingredient Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 239000011737 fluorine Substances 0.000 claims description 9
- 229910052731 fluorine Inorganic materials 0.000 claims description 9
- 210000000988 bone and bone Anatomy 0.000 claims description 6
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 229960004711 sodium monofluorophosphate Drugs 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 150000001450 anions Chemical class 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- -1 orthophosphate anion Chemical class 0.000 claims description 3
- 239000008024 pharmaceutical diluent Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 229940124597 therapeutic agent Drugs 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 230000003472 neutralizing effect Effects 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 229910052718 tin Inorganic materials 0.000 claims description 2
- 239000011135 tin Substances 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims 1
- 239000011573 trace mineral Substances 0.000 claims 1
- 235000013619 trace mineral Nutrition 0.000 claims 1
- 241001465754 Metazoa Species 0.000 description 23
- 238000012360 testing method Methods 0.000 description 20
- 239000000243 solution Substances 0.000 description 19
- 230000000694 effects Effects 0.000 description 17
- 238000011282 treatment Methods 0.000 description 17
- 210000003298 dental enamel Anatomy 0.000 description 15
- 229940079593 drug Drugs 0.000 description 14
- 230000007547 defect Effects 0.000 description 10
- 210000003296 saliva Anatomy 0.000 description 10
- 208000002064 Dental Plaque Diseases 0.000 description 8
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 8
- 239000004075 cariostatic agent Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 230000001939 inductive effect Effects 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 206010061291 Mineral deficiency Diseases 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- 230000002250 progressing effect Effects 0.000 description 4
- 102000016943 Muramidase Human genes 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229960005069 calcium Drugs 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 150000002222 fluorine compounds Chemical class 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000004325 lysozyme Substances 0.000 description 3
- 229960000274 lysozyme Drugs 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 230000008092 positive effect Effects 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 238000004820 blood count Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 210000003464 cuspid Anatomy 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 210000004283 incisor Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 244000005706 microflora Species 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 230000007665 chronic toxicity Effects 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 239000008023 pharmaceutical filler Substances 0.000 description 1
- 229940085991 phosphate ion Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011158 quantitative evaluation Methods 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000036266 weeks of gestation Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58044537A JPS59175435A (ja) | 1983-03-18 | 1983-03-18 | 虫歯治療剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58044537A JPS59175435A (ja) | 1983-03-18 | 1983-03-18 | 虫歯治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59175435A true JPS59175435A (ja) | 1984-10-04 |
| JPH0159251B2 JPH0159251B2 (enrdf_load_stackoverflow) | 1989-12-15 |
Family
ID=12694254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58044537A Granted JPS59175435A (ja) | 1983-03-18 | 1983-03-18 | 虫歯治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59175435A (enrdf_load_stackoverflow) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6393710A (ja) * | 1986-09-25 | 1988-04-25 | コルゲート・パーモリブ・カンパニー | フッ素イオンとカルシウムの持続放出組成物 |
| JPS6393709A (ja) * | 1986-09-25 | 1988-04-25 | コルゲート・パーモリブ・カンパニー | フッ素とカルシウムの持続放出組成物 |
| WO1996023805A1 (en) * | 1995-02-02 | 1996-08-08 | Kabushiki Kaisha Sangi | Completely dissolved bone tissue and method for producing the same |
-
1983
- 1983-03-18 JP JP58044537A patent/JPS59175435A/ja active Granted
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6393710A (ja) * | 1986-09-25 | 1988-04-25 | コルゲート・パーモリブ・カンパニー | フッ素イオンとカルシウムの持続放出組成物 |
| JPS6393709A (ja) * | 1986-09-25 | 1988-04-25 | コルゲート・パーモリブ・カンパニー | フッ素とカルシウムの持続放出組成物 |
| WO1996023805A1 (en) * | 1995-02-02 | 1996-08-08 | Kabushiki Kaisha Sangi | Completely dissolved bone tissue and method for producing the same |
| US5897881A (en) * | 1995-02-02 | 1999-04-27 | Kabushiki Kaisha Sangi | Hard tissue intactly dissolved materials and method for producing the same |
| CN1070497C (zh) * | 1995-02-02 | 2001-09-05 | 三仪股份有限公司 | 骨组织完全溶解体的制造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0159251B2 (enrdf_load_stackoverflow) | 1989-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mandel | The role of saliva in maintaining oral homeostasis | |
| JP5684454B2 (ja) | 口腔ケア用の治療及び予防組成物 | |
| JP4746441B2 (ja) | 過飽和溶液中のカルシウムおよびリン酸イオンからなるうがい薬 | |
| EP3661490B1 (en) | Composition for use in the prevention and/or treatment of oncologic treatment induced orogastrointestinal mucositis | |
| US4419341A (en) | Drug for treatment of dental caries | |
| JPH10152426A (ja) | 漢方薬入り口腔衛生剤 | |
| JPH02504030A (ja) | 歯を清浄にしかつフッ化物を添加する錠剤 | |
| EP3046632B1 (en) | Oral hygiene compositions | |
| US4078053A (en) | High-concentration fluoride preparations and use for preventing caries | |
| Taylor | Efficacy and economic evaluation of pilocarpine in treating radiation-induced xerostomia | |
| JPS59175435A (ja) | 虫歯治療剤 | |
| US20060239938A1 (en) | Dental balm and method of prevention of damage to teeth | |
| KR0179523B1 (ko) | 치은염 치료용 유향과 창출 추출물 함유 치약조성물 | |
| EP0270977A1 (en) | Anticariogenic compositions | |
| Kaur et al. | The immediate Term effect of chewing commercially available Meswak (Salvadora persica) on levels of Calcium, Chloride, Phosphate and Thiocyanate in whole saliva | |
| RU2112501C1 (ru) | Гелевая зубная паста (варианты) | |
| Budimir et al. | Clinical characteristics of topical propolis induced oral lesions | |
| JP3140412B2 (ja) | 牛膝または楡白皮抽出物を含有する口腔用組成物 | |
| CA2555095A1 (en) | Dental balm and method of prevention of damage to teeth | |
| KR100589951B1 (ko) | 노박덩굴 추출물을 함유한 구강조성물 | |
| DE3310182C2 (enrdf_load_stackoverflow) | ||
| Úbeda et al. | Fluoride uptake in dental enamel after using fluoridated dentifrice, preceded or not by a CaCl2 solution rinse | |
| BR112022012549B1 (pt) | Composição para remineralizar esmalte dentário | |
| JPS59175412A (ja) | 虫歯予防効果を有する治療及び予防用顆粒製剤 | |
| CN114929179A (zh) | 用于使牙釉质再矿化的组合物 |